Drug Trial Radar · NCT05461573
Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females
Last checked: Nov 19, 2026Latest source record: Oct 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,542
Actual
Start
Aug 2, 2022
Primary completion
Aug 5, 2024
Study completion May 27, 2025
Sponsor
- Lead sponsor
- Insud PharmaIndustry
- Sponsor type
- Industry
- Collaborators
- Chemo Research
- First posted
- Jul 18, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 13 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will be in two parts, Part A and Part B. The primary objective of Part A is to evaluate the contraceptive efficacy of LPRI-CF113. The secondary objective of Part A is to evaluate the safety and tolerability of LPRI-CF113. The primary objective of Part B is to evaluate the impact of LPRI-CF113 on bone mineral density (BMD) at the lumbar spine (L1-L4) after 12 months (13 medication cycles). The secondary objective of Part B is to evaluate the impact of LPRI-CF113 on BMD and bone turnover after 12 months (13 medication cycles) at the femoral neck, total hip, and total body.
Conditions
- Contraception
- Change in Bone Mineral Density
Interventions
DrospirenoneDrug
LPRI-CF113 consists of 24 active white tablets containing drospirenone (DRSP) 4 mg followed by 4 active pink tablets containing DRSP 2.8 mg, taken orally once daily for 28 consecutive days, in consecutive cycles for 12 months (13 medication cycles) without a break in daily tablet intake.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A (Efficacy Assessment): Number of pregnancies in subjects ≤35 years of age (at the time of screening).Time frame: 12 months
Locations
47 sites in 2 countries. Site status is shown where the registry gives one.
Alabama Clinical Therapeutics, LLC
Alabaster, Alabama
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama
Del Sol Research Management
Tucson, Arizona
Eclipse Clinical Research
Tucson, Arizona
Cornerstone Research Institute - Longwood
Altamonte Springs, Florida
Encore Medical Research of Boynton Beach LLC.
Boynton Beach, Florida
Women's Medical Research Group
Clearwater, Florida
Direct Helpers Research Center
Hialeah, Florida
Inpatient Research Clinic, LLC
Hialeah, Florida
Vital Pharma Research, Inc.
Hialeah, Florida
Encore Medical Research, LLC
Hollywood, Florida
Global Research Associates
Homestead, Florida
Altus Research
Lake Worth, Florida
Florida International Medical Research
Miami, Florida
New Age Medical Research Corporation
Miami, Florida
SJ Research Institute
Miami, Florida
Segal Institute for Clinical Research
North Miami, Florida
American Research Centers of Florida
Pembroke Pines, Florida
Comprehensive Clinical Trials
West Palm Beach, Florida
Encore Medical Research of Weston LLC
Weston, Florida
Fellows Research Alliance
Savannah, Georgia
Clinical Research Prime
Idaho Falls, Idaho
Leavitt Clinical Research
Idaho Falls, Idaho
Rosemark WomenCare Specialists
Idaho Falls, Idaho
Praetorian Pharmaceutical Research
Marrero, Louisiana
Southern Clinical Research Associates
Metairie, Louisiana
Eastern Clinical Research Associates
New Orleans, Louisiana
Eastern Carolina Women's Center
New Bern, North Carolina
Unified Women's Clinical Research - Raleigh
Raleigh, North Carolina
Unified Women's Clinical Research - Winston-Salem
Winston-Salem, North Carolina
Clinohio Research Services
Columbus, Ohio
AC Clinical Research
Tiffin, Ohio
Clinical Research of Philadelphia
Philadelphia, Pennsylvania
The Research Center of the Upstate
Greenville, South Carolina
Coastal Carolina Research Center
North Charleston, South Carolina
Chattanooga Medical Research
Chattanooga, Tennessee
Central Texas Clinical Research
Austin, Texas
Discovery Clinical Trials
Dallas, Texas
TMC Life Research
Houston, Texas
FMC Science
Lampasas, Texas
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.